Workflow
Jade Biosciences Announces $45 Million Private Placement
Globenewswire· 2025-12-15 12:00
SAN FRANCISCO and VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it has entered into a securities purchase agreement with BB Biotech for a private placement financing that is expected to result in gross proceeds of approximately $45 million to the Company, before offering expenses. Pursuant to the ...
GXO Announces Brad Jacobs Will Step Down as Non-Executive Chairman
Globenewswire· 2025-12-15 12:00
Patrick Byrne Patrick Byrne will assume the role of Non-Executive Chairman Seasoned Executive Patrick Byrne to Become Non-Executive Chairman GREENWICH, Conn., Dec. 15, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced that Brad Jacobs will step down as Non-Executive Chairman of the Board, effective December 31, 2025. Patrick Byrne will assume the role of Non-Executive Chairman at that time. The chairman transition follo ...
Hain Celestial Appoints Alison E. Lewis President and Chief Executive Officer
Globenewswire· 2025-12-15 12:00
HOBOKEN, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (“Hain Celestial” or the “Company”) (Nasdaq: HAIN), today announced that Alison E. Lewis has been appointed President and Chief Executive Officer, effective immediately. Ms. Lewis had been serving as Hain Celestial’s Interim President and Chief Executive Officer since May 2025. Ms. Lewis will also continue in her role as a member of the Board of Directors (the “Board”).Dawn Zier, Chair of the Board, said, “The Board has had the ...
Flagship Communities Real Estate Investment Trust Announces December 2025 Cash Distribution
Globenewswire· 2025-12-15 12:00
Not for distribution to U.S. newswire services or dissemination in the United States TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT”) (TSX:MHC.U) (TSX:MHC.UN) today announced a cash distribution of US$0.0545 per REIT unit for the month of December 2025, representing US$0.654 per REIT unit on an annualized basis. Payments will be made on or about January 15, 2026, to unitholders of record as of the close of business on December 31, 2025. ...
Whitestone REIT Receives $33.4 Million Payment From Pillarstone Settlement Agreement
Globenewswire· 2025-12-15 11:55
Core Insights - Whitestone REIT received $33.4 million from Pillarstone Capital REIT Operating Partnership following a bankruptcy court-approved settlement agreement [1] - The settlement directs the Partnership to distribute remaining funds after specific payments, enhancing Whitestone's financial position [2] - Whitestone expects to receive an additional $4.0 million in cash and excess reserves in 2026, alongside a prior payment of $13.6 million [3] - The company aims for consistent long-term growth of 5-7% annual Core FFO per share, with the recent settlement strengthening its balance sheet [4] - Whitestone has acquired two properties and disposed of one, indicating a strategic focus on growth and value creation [5] Company Overview - Whitestone REIT is a community-centered real estate investment trust that operates open-air retail centers in rapidly growing markets [6] - The company's centers focus on convenience and feature a mix of service-oriented tenants, which are crucial for its success [7]
Skeena Gold & Silver Announces Successful Tahltan Nation Vote Supporting the Eskay Creek Impact Benefit Agreement
Globenewswire· 2025-12-15 11:50
Core Points - The Tahltan Nation has voted in favor of the Impact Benefit Agreement (IBA) for the Eskay Creek Gold-Silver Project, which is fully owned by Skeena Resources Limited [1][2] - The IBA aims to establish a framework for shared benefits, including employment opportunities, training initiatives, and financial participation for the Tahltan Nation [5] - Skeena Resources is focused on advancing the Eskay Creek Project, which is expected to be one of the highest-grade and lowest-cost open-pit precious metals mines globally [3] Group 1 - The Tahltan Central Government Board of Directors will consider a decision regarding consent for the Eskay Creek Project in January 2026 [2] - Walter Coles, Executive Chairman of Skeena, expressed gratitude to the Tahltan leadership for their collaboration and emphasized the innovative nature of the IBA [2] - The IBA is seen as a foundation for a long-term partnership between Skeena and the Tahltan Nation, reflecting their environmental, cultural, and economic priorities [2] Group 2 - Skeena Resources is committed to sustainable mining practices and aims to foster positive relationships with Indigenous communities [3] - The Eskay Creek Project is located in the Golden Triangle of British Columbia and is expected to produce substantial silver by-products [3] - The IBA includes provisions for employment and business opportunities for Tahltan members, training initiatives, and funding for facilities benefiting Tahltan elders [5]
Volatus Aerospace Awarded $9M Defence Contract from NATO Partner, Accelerating Growth in Uncrewed Systems
Globenewswire· 2025-12-15 11:45
MONTRÉAL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQB:TAKOF) (Frankfurt:A3DP5Y/ABB.F) (“Volatus” or “the Company”), a leader in uncrewed, aerial, and defense technology solutions, is pleased to announce that it has been awarded a defence contract valued at up to CAD $9 million to supply an allied defence organization with a next-generation interim training system for Intelligence, Surveillance, and Reconnaissance (ISR) operations. The award is structured over two years, with a ...
Rekor Systems Announces Pricing of $15.0 Million Underwritten Registered Direct Offering
Globenewswire· 2025-12-15 11:45
COLUMBIA, Md., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Rekor Systems, Inc. (Nasdaq: REKR) (“Rekor,” “we,” “our” or the “Company”), a leader in developing and implementing state-of-the-art roadway intelligence technology, today announced the pricing of an underwritten registered direct offering of 8,571,428 units at a public offering price of $1.75 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.40 per share. The warran ...
National Fuel Announces Successful $350 Million Private Placement of Common Stock
Globenewswire· 2025-12-15 11:45
WILLIAMSVILLE, N.Y., Dec. 15, 2025 (GLOBE NEWSWIRE) -- National Fuel Gas Company (“National Fuel” or the “Company”) announced today that it has entered into a subscription agreement (the “Subscription Agreement”) with a group of investors (the “Investors”) for a private placement of common stock (the “Offering”). Upon closing of the Offering, the Company expects to receive gross proceeds of $350 million, before deducting fees and expenses, resulting from the sale of approximately 4.4 million shares of commo ...
Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
Globenewswire· 2025-12-15 11:30
Core Insights - Mivocabtagene autoleucel (miv-cel) has shown transformative results in treating stiff person syndrome (SPS), potentially becoming the first FDA-approved CAR T-cell therapy for autoimmune diseases [1][3][5] - The company plans to submit a Biologics License Application (BLA) for miv-cel in the first half of 2026 [1][5][8] Efficacy - Miv-cel demonstrated statistically significant improvements in all primary and secondary endpoints, reversing disability and eliminating the need for immunotherapies after a single dose [1][5][6] - The primary endpoint, the timed 25-foot walk (T25FW), showed a median improvement of 46% at Week 16 compared to baseline, with 81% of patients exceeding a 20% improvement [6][12] - Secondary endpoints also showed highly statistically significant benefits, with all p-values <0.0001, including improvements in the Modified Rankin Scale (mRS) and Hauser Ambulation Index (HAI) [6][12] Safety - Miv-cel was well-tolerated, with no high-grade cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS) observed [1][14] - Grade 3/4 neutropenia was noted but was manageable, indicating a favorable safety profile [14] Clinical Trial Overview - The KYSA-8 trial is a single-arm registrational Phase 2 study involving 26 patients with SPS who had inadequate responses to non-approved treatments [4][11] - Patients received a single dose of miv-cel after lymphodepletion with cyclophosphamide and fludarabine, with follow-up for one year [12] Company Background - Kyverna Therapeutics is focused on developing cell therapies for autoimmune diseases, with miv-cel as its lead candidate [17] - The company has received Regenerative Medicine Advanced Therapy and Orphan Drug designations for miv-cel in the context of SPS [8][18]